Surprising Reason Americans Are Still Struggling to Get Off the Couch
The surprising part? It's not the pandemic itself that's holding us back. It's what we kept from that time: virtual meetings, delivery apps, and digital convenience that eliminate nearly all incidental movement.
Between 2017 and 2020, average sedentary time hovered around 5.9 hours per day. Despite reopening efforts and a return to daily routines, Americans today are still logging six hours of sitting time daily, and that number hasn't budged since 2021. Experts believe the technology we adopted during lockdowns plays a bigger role than we realize.
Zoom meetings replaced office walks. Grocery delivery replaced cart-pushing. And once-automatic steps, like walking into work or grabbing lunch across the street, have quietly disappeared. The shift wasn't temporary. For many, it became the new baseline.
And that matters. Yahoo reported that prolonged sitting is linked to a higher risk of heart disease, type 2 diabetes, and even certain cancers. The phrase 'sitting is the new smoking' might sound overused, but it's rooted in the reality that a sedentary lifestyle is still a leading health concern in the U.S.
That doesn't mean everyone needs to hit the gym seven days a week. In fact, experts say daily movement—even in small doses—can make a measurable difference. Taking walking breaks, adding 'exercise snacks' throughout the day, or choosing to run errands in person instead of online are all ways to offset the damage of desk-bound days.
There's also a growing divide in who's able to get moving again. Gym membership rates hit a record high in 2024, but researchers note that those benefits mostly reach higher-income Americans. For people working multiple jobs or without flexible schedules, building in movement remains a challenge.
The solution isn't more pressure. It's more purpose. We don't need to overhaul our lives. We just need to start moving in the right direction, one step at a time.Surprising Reason Americans Are Still Struggling to Get Off the Couch first appeared on Men's Journal on Jul 7, 2025

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Exact Sciences Schedules Second Quarter 2025 Earnings Call
MADISON, Wis., July 14, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its second quarter 2025 financial results after the close of the U.S. financial markets on August 6, 2025. Following the release, company management will host a webcast and conference call at 5 p.m. ET to discuss financial results and business progress. Second quarter 2025 webcast & conference call details Date: Wednesday, August 6, 2025 Time: 5 p.m. ET Webcast: The live webcast can be accessed at Telephone: Domestic callers, dial 888-330-2384International callers, dial +1 240-789-2701 Access code for both domestic and international callers: 4437608 A replay of the webcast will be available at The webcast, conference call, and replay are open to all interested parties. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company's growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit follow @ExactSciences on X, or connect on LinkedIn and Facebook. View source version on Contacts Investor Contact:Derek Leckow608-893-0009investorrelations@ 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤


Medscape
43 minutes ago
- Medscape
ACG Refreshes Preventive Care in IBD Guidance
The American College of Gastroenterology has issued an updated clinical practice guideline on preventive care for patients with inflammatory bowel disease (IBD) that covers vaccinations, cancer surveillance, bone health monitoring, lifestyle counseling, and other important 'health maintenance' issues. 'Patients with IBD often consider their gastroenterologist to be the primary provider of care. Because more than 70% of patients with IBD will at some time be on medications that will affect the immune system, it is essential that the gastroenterology team promote vaccinations and other health maintenance activities,' said the writing group, led by Francis Farraye, MD, director, Inflammatory Bowel Disease Center, Mayo Clinic, Jacksonville, Florida. The panel noted that referral to dermatology, endocrinology, gynecology, primary care, and psychiatry 'may be necessary on a case-by-case basis. Coordination between the gastroenterology team and other providers is crucial for improving the quality of care that we provide to our patients living with IBD.' The 27-page updated guideline on preventive care in IBD was published earlier this month in The American Journal of Gastroenterology , along with a one-page visual highlights summary. The update provides 12 recommendation statements and 11 key concepts. It replaces the 2017 ACG guideline on preventive care in IBD. Prioritize Vaccinations 'Patients with IBD are at increased risk for infections as a consequence of their disease, and this risk may be amplified by certain immune-modifying therapies,' the writing group noted. They strongly recommend that all adults with IBD aged 50 years and older with no prior pneumococcal vaccination receive the pneumococcal conjugate vaccine (PCV) 20 or PCV21. There is a conditional recommendation that adults aged 19-49 years on immune-modifying therapy and with no prior pneumococcal vaccination also receive the PCV20 or PCV21 vaccine. Patients with IBD who previously received a pneumococcal vaccine should follow revaccination advice from the CDC. Vaccination against herpes zoster with the two-dose inactive recombinant herpes zoster vaccine is advised for patients with IBD aged 50 years or more and for younger patients about to start or already on immune-modifying therapy (both conditional recommendations). Other conditional recommendations include vaccination against SARS-CoV-2 in accordance with national guidelines and live rotavirus vaccine for children with in-utero exposure to biologics. In addition, all adults with IBD should receive annual influenza vaccines; those receiving immune-modifying therapies and their household contacts should receive the nonlive trivalent inactivated influenza vaccine but not the live inhaled influenza vaccine. Respiratory syncytial virus (RSV) vaccine is advised for all patients aged 75 and older and for those aged 50-74 years with certain chronic medical conditions or other risk factors for severe RSV disease. Household members of patients receiving immune-modifying therapies can receive live vaccines with certain precautions. Vaccinations against tetanus, diphtheria, and pertussis (Tdap), hepatitis A virus, human papillomavirus (HPV), and meningococcus should be administered according to CDC recommendations. Adults with IBD should receive vaccination against hepatitis B if not immune. Skin and Cervical Cancer Surveillance 'In addition to vaccination issues, it is important to identify subgroups of patients with IBD that have an increased risk of developing cervical cancer, nonmelanoma skin cancer (NMSC), and melanoma,' the panel said. In women with IBD on immune-modifying therapies, there is a conditional recommendation for annual cervical cancer screening within a year of sexual activity onset; in women younger than 30 years, screening should continue for 3 consecutive years before increasing to every 3 years. Annual screening for melanoma (independent of biologic therapy) and for NMSC (particularly in adults aged 50+) is also suggested (conditional recommendations). Bone and Mental Health Patients with IBD are at increased risk for bone loss, which can lead to osteopenia and osteoporosis. The guideline suggests screening for osteoporosis with bone mineral density testing at the time of diagnosis and periodically after diagnosis (conditional recommendation). Given data showing worse outcomes among smokers with IBD, smoking cessation counseling is strongly encouraged. The guideline also addresses the mental health of patients with IBD. 'Current evidence suggests that mood disorders, in particular depression and anxiety, are more prevalent in patients with IBD than the background population, the panel noted. Therefore, they recommend that all patients with IBD be screened for depression and anxiety at baseline and annually. Patients who screen positive for anxiety and/or depression should be referred for counseling/therapy.


Bloomberg
44 minutes ago
- Bloomberg
Epstein-Barr Is More Dangerous Than You Think
Hi it's Karoline in Singapore, where one in four people will get cancer in their lifetime. A recent study found a common virus could be more powerful in causing cancers than previously thought. More on that in a moment, but first ... The Epstein-Barr virus is one of the most common human viruses, with more than 90% of people in the world being infected at some point of their lives. It's spread by saliva and causes mononucleosis, known as the 'kissing disease.' Though EBV generally causes mild flu-like symptoms, it has been linked to immune dysfunctions, lymphomas and nose and stomach cancers.